Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial
Elizabeth R. Brown(Fred Hutch Cancer Center), Sharon L. Hillier(Magee-Womens Research Institute), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Craig W. Hendrix(Unknown), Jared M. Baeten(University of Washington), Ariane van der Straten(University of California, San Francisco), Flavia Matovu Kiweewa(MUJHU Research Collaboration), Mark A. Marzinke(Family Health International 360), Nyaradzo Mgodi(University of Zimbabwe), Lydia Soto‐Torres(National Institutes of Health)
Cited by 78
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768
Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis
|New England Journal of Medicine|2000|679